Tag: CORO
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
Immunocompromised patients can still receive convalescent plasma
Dynamically Updating Models Can Improve Prediction of COVID-19 Survival
Drift in model calibration performance was detected immediately, with minor fluctuations in discrimination
Study Looks at Extent of Residual Lung Abnormalities After COVID-19 Hospitalization
Posthospitalization prevalence of residual lung abnormalities estimated at 11.7 percent in sensitivity analyses
PTSD, Psychiatric Disorders Tied to Higher Risk for Severe COVID-19 Outcomes
Findings seen even when accounting for sociodemographic factors, comorbidities, and smoking
Temporal Improvement Seen in Standard of Care for Hospitalized COVID-19 Patients
Outcomes improved from Adaptive COVID-19 Treatment Trial-2 to ACTT-3, although potential explanatory factors were similar
Overactive Bladder Common in Postacute COVID-19 Syndrome
COVID-19 may lead to new or worsening urinary symptoms in men and women
Increase Seen in Years of Life Lost Per COVID-19 Death in 2021
YLL increased 35.7 percent per COVID-19 death in 2021 versus 2020 as median age of COVID-19 deaths decreased
Medical Masks Similar to N95 Respirators for Preventing COVID-19
No significant difference seen with medical masks versus N95 respirators for health care personnel providing care to COVID-19 patients
Studies Compare Various Treatments for COVID-19
Sotrovimab effective compared with molnupiravir; second study shows no effect for angiotensin receptor blockers in terms of illness severity
New COVID-19 Variant XBB Gaining Ground Among Americans
New omicron subvariant is taking hold in the United States, health officials say, though it does not look more severe than its predecessors
